M&As in the pharmaceutical and biotech industries

Our corporate finance team is considered to be among the leading in Denmark and we are the law firm with the highest number of transactions in Denmark in the period 2004-2009 (According to Mergermarket). We provide advice on all types of M&A, including within the pharmaceutical and biotech industries and cover all phases of a transaction, be it public or private.

Investing in pharmaceutical and biotech companies

Due to our extensive experience and knowledge of the industry and trends, we provide advice in all scenarios regarding an investment in a pharmaceutical or biotech company (for instance investment agreements, shareholders' agreements and articles of association).

Legal due diligence

We have extensive experience and knowledge in undertaking, conducting and coordinating legal due diligences regardless of whether it involves assisting a seller in the establishing of a data room and the subsequent due diligence and negotiation processes or assisting a potential buyer with the acquisition of a target company. Due diligence of a pharmaceutical or biotech company would involve our specialist departments in relation to IP law and Life Science issues.

Read more about Plesner's professional qualifications in mergers & acquisitions.

© Plesner  TEL +45 33 12 11 33 - Amerika Plads 37 - 2100 Copenhagen - CVR 42 93 85 13